Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study

Abstract Background While the number of therapeutic options for treating inflammatory bowel diseases (IBD) is increasing, evidence for rational treatment decisions is scarce in many cases. In particular, appropriate biomarkers to predict the response to the anti-α4β7 integrin antibody vedolizumab ar...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Clarissa Allner, Michaela Melde, Emily Becker, Friederike Fuchs, Laura Mühl, Entcho Klenske, Lisa Müller, Nadine Morgenstern, Konstantin Fietkau, Simon Hirschmann, Raja Atreya, Imke Atreya, Markus F. Neurath, Sebastian Zundler
Формат: Artigo
Язык:Inglês
Опубликовано: BMC 2020-04-01
Серии:BMC Gastroenterology
Предметы:
Inflammatory bowel diseases
T cells
Vedolizumab
Adhesion
Gut homing
Online-ссылка:http://link.springer.com/article/10.1186/s12876-020-01253-8
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы